心肺運動負荷試験市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別-2025～2032年産業予測

心肺運動負荷試験の2023年の市場規模は37億米ドルで、2024年の38億7,000万米ドルから2032年には55億9,000万米ドルに成長し、予測期間（2025～2032年）のCAGRは4.7%で成長する展望です。

心血管疾患は、早急な対策と診断プロトコルの改善が求められる世界の健康危機の深刻化です。European Heart Networkの2021年のデータによると、欧州連合（EU）では6,000万人以上が罹患しており、毎年1,300万人近くが新たに診断されています。この憂慮すべき有病率は、早期診断と介入を促進するためのストレス試験手順の実施など、プロアクティブな戦略の緊急の必要性を浮き彫りにしています。心血管疾患の罹患率の増加は、個人の健康を脅かすだけでなく、世界中の医療システムに大きな負担をかけています。そのため、この増大する公衆衛生問題に効果的に取り組み、影響を受ける人々の予後を改善するための革新的なソリューションと先進的診断ツールが急務となっています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の展望
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主要市場の考察

• 重要成功要因
• 競合の程度
• 主要投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

心肺運動負荷試験市場規模：製品別&CAGR（2025～2032年）

• 市場概要
• 単一光子放出コンピュータ断層撮影（SPECT）
• 心肺運動負荷試験（CPET）システム
• 心エコー試験
• パルスオキシメーター
• ストレス血圧モニター
• その他

心肺運動負荷試験市場規模：用途別&CAGR（2025～2032年）

• 市場概要
• 酸素摂取量
• 二酸化炭素
• 分時換気量
• 無酸素性閾値

心肺運動負荷試験市場規模：エンドユーザー別&CAGR（2025～2032年）

• 市場概要
• 診断センター
• 外来センター
• クリニック
• 病院
• その他

心肺運動負荷試験市場規模&CAGR（2025～2032年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他のラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他の中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主要市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

    主要企業プロファイル

    • COSMED SRL（イタリア）
    • Nihon Kohden Corporation（日本）
    • Schiller AG（スイス）
    • Masimo Corporation（米国）
    • Cardinal Health（米国）
    • SunTech Medical, Inc.（米国）
    • Geratherm Medical AG（ドイツ）
    • Spacelabs Healthcare（米国）
    • Welch Allyn（米国）
    • Microlife Medical Home Solutions Inc.（スイス）
    • Medisoft SA（ベルギー）
    • CAIRE Inc.（米国）
    • Allengers（インド）
    • Cardioline SpA（イタリア）
    • Clarity Medical（インド）
    • Innomed Medical（ハンガリー）
    • Valencell（米国）
    • INTCO Medical Technology Co., Ltd.（中国）

結論と提言

Cardiopulmonary Exercise Testing Market size was valued at USD 3.7 billion in 2023 and is poised to grow from USD 3.87 billion in 2024 to USD 5.59 billion by 2032, growing at a CAGR of 4.7% during the forecast period (2025-2032).

Cardiovascular diseases are an escalating global health crisis that demands immediate action and improved diagnostic protocols. According to 2021 data from the European Heart Network, over 60 million people in the European Union are affected, with nearly 13 million new diagnoses each year. This alarming prevalence highlights an urgent need for proactive strategies, such as implementing stress testing procedures to facilitate early diagnosis and intervention. The rising incidence of cardiovascular conditions not only threatens individual health but also places significant strain on healthcare systems worldwide. Consequently, there is a pressing requirement for innovative solutions and advanced diagnostic tools to effectively tackle this growing public health issue and improve outcomes for affected populations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cardiopulmonary Exercise Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cardiopulmonary Exercise Testing Market Segments Analysis

Global Cardiopulmonary Exercise Testing Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Single-Photon Emission Computed Tomography (SPECT), Cardiopulmonary Exercise Testing (CPET) Systems, Echocardiogram, Pulse Oximeters, Stress Blood Pressure Monitors and Others. Based on Application, the market is segmented into Oxygen Uptake, Carbon Dioxide, Minute Ventilation and Anaerobic Threshold. Based on End User, the market is segmented into Diagnostic Centers, Ambulatory Centers, Clinics, Hospitals and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cardiopulmonary Exercise Testing Market

One key market driver for the Global Cardiopulmonary Exercise Testing (CPET) market is the rising prevalence of cardiovascular diseases and respiratory disorders, which necessitates accurate diagnostic tools for effective patient management. As the population ages and lifestyles become more sedentary, the incidence of conditions such as coronary artery disease, chronic obstructive pulmonary disease (COPD), and heart failure continues to climb. This growing patient demographic is driving healthcare providers to adopt CPET as a standard diagnostic procedure, enhancing the demand for advanced exercise testing equipment and services that can evaluate an individual's exercise capacity and cardiovascular response more efficiently.

Restraints in the Cardiopulmonary Exercise Testing Market

The growth of the cardiopulmonary exercise testing market faces significant challenges primarily due to the high costs linked with these diagnostic procedures. The substantial expenses incurred in acquiring, implementing, and maintaining the necessary equipment can act as a major barrier to market expansion. These financial constraints may restrict access to cardiopulmonary exercise testing for healthcare providers and patients alike, potentially hindering its broader acceptance and utilization. Moreover, the economic implications of these tests may present difficulties for healthcare facilities, especially in areas operating under limited budgets, ultimately impacting the overall adoption of this essential diagnostic method.

Market Trends of the Cardiopulmonary Exercise Testing Market

The cardiopulmonary exercise testing market is experiencing noteworthy growth, bolstered by the continuous innovation and diverse offerings from leading industry players. Partnerships, such as the May 2022 collaboration between MGC Diagnostics and UK-based Bedfont Scientific, highlight a strategic focus on integrating advanced technologies, including breath analysis systems like the NObreath fractional exhaled nitric oxide test monitor. Such alliances not only enhance product portfolios but also improve testing capabilities in various settings, from hospitals to remote locations. As these collaborative efforts gain momentum, the market is expected to flourish, driven by advancements that address the increasing demand for comprehensive cardiopulmonary evaluations.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cardiopulmonary Exercise Testing Market Size by Product & CAGR (2025-2032)

• Market Overview
• Single-Photon Emission Computed Tomography (SPECT)
• Cardiopulmonary Exercise Testing (CPET) Systems
• Echocardiogram
• Pulse Oximeters
• Stress Blood Pressure Monitors
• Others

Global Cardiopulmonary Exercise Testing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Oxygen Uptake
• Carbon Dioxide
• Minute Ventilation
• Anaerobic Threshold

Global Cardiopulmonary Exercise Testing Market Size by End User & CAGR (2025-2032)

• Market Overview
• Diagnostic Centers
• Ambulatory Centers
• Clinics
• Hospitals
• Others

Global Cardiopulmonary Exercise Testing Market Size & CAGR (2025-2032)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• COSMED SRL (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schiller AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Masimo Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SunTech Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Geratherm Medical AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spacelabs Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Welch Allyn (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microlife Medical Home Solutions Inc. (Swtzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisoft SA (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CAIRE Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allengers (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardioline SpA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clarity Medical (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Innomed Medical (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valencell (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• INTCO Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations